Turnill, who joined the firm’s Sydney office today (6 May), will co-chair Bakers’ Australian life sciences group with partner Ben McLaughlin.
Turnill has more than 20 years’ experience as a product liability litigator and regulatory specialist, having advised pharmaceutical, medical technology, biotechnology and other life sciences companies in Australia, the UK, Europe, US and Asia. Her key clients include several top-20 global pharmaceutical and medical technology companies.
Over her career in Australia and the UK, Turnill has advised on a broad range of issues arising in the life cycle of drug development and commercialisation. These have included: product liability proceedings; class actions; therapeutic goods legislation and regulations; crisis and risk management; product stewardship and compliance, and PBS pricing and reimbursement issues.
On Turnill’s appointment, McLaughlin said: “Amanda will add depth and experience to our strong existing team of lawyers advising life sciences clients … she was the global co-chair of life sciences at her previous firm.
"Before becoming a lawyer, Amanda was a registered nurse, so has been able to combine her knowledge of health issues and her interest in the life sciences industry with law."
Turnill added: “I am excited to be joining a strong life sciences team in Australia ... I am confident that Baker & McKenzie's approach to servicing clients in this area and the industry knowledge of the wider team means we will be able to provide a highly-specialised service to life sciences clients.”
Turnill is chair of AusBiotech's NSW Branch Committee and has been listed as a leading lawyer in numerous legal directories over the past decade.